SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-004030
Filing Date
2023-03-16
Accepted
2023-03-16 16:30:56
Documents
14
Period of Report
2023-03-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20230316x8k.htm   iXBRL 8-K 37499
2 EX-99.1 bpth-20230316xex99d1.htm EX-99.1 25701
3 GRAPHIC bpth-20230316xex99d1001.jpg GRAPHIC 8281
  Complete submission text file 0001558370-23-004030.txt   201344

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20230316.xsd EX-101.SCH 3153
5 EX-101.LAB bpth-20230316_lab.xml EX-101.LAB 15926
6 EX-101.PRE bpth-20230316_pre.xml EX-101.PRE 10126
8 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20230316x8k_htm.xml XML 4867
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 23739250
SIC: 2834 Pharmaceutical Preparations